AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Doxorubicin Hydrochloride in Nigeria
3 products registered with NAFDAC — 3 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Caelyx Injection** Solution for injection | B4-8252 | PharmaSymbiosis Limited | active | 29 Nov 2028 |
| Adriblastina CS 10 mg/5 mL Injection** Solution for injection | B4-1159 | Pfizer Specialties Ltd | active | 23 Jun 2026 |
| Adriblastina CS 50 mg/25 mL Injection** Solution for injection | B4-1160 | Pfizer Specialties Ltd | active | 23 Jun 2026 |
Doxorubicin Hydrochloride — NAFDAC Registration Details
NAFDAC (Nigeria) has 3 registered products containing Doxorubicin Hydrochloride, of which 3 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Doxorubicin Hydrochloride registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.